DistantNews
Support us
🇫🇷 France /Health & Science

Obesity: Wegovy and Mounjaro Gain Ground Among Children

From Le Figaro · () French

Translated from French and summarized by DistantNews. Read the original for the full story.

At a glance

Analysis Named sources Context piece
  • A NYU Grossman School of Medicine study found that prescriptions of GLP-1 anti-obesity drugs for US children aged 8 to 11 rose 310-fold between 2019 and 2026.
  • Researchers reviewed the medical records of more than 3.5 million children with obesity but no diabetes; 0.6% received an anti-GLP-1 prescription.
  • Prescriptions remained largely concentrated among children with obesity-related metabolic complications, according to a physician quoted by Le Figaro.

Wegovy and Mounjaro, already established in adult obesity treatment, are increasingly reaching younger patients. In the United States, prescriptions for children aged 8 to 11 with obesity rose 310-fold between 2019 and 2026, according to a study by NYU Grossman School of Medicine published in Pediatrics.

The researchers examined the medical records of more than 3.5 million children with obesity who did not have diabetes. Across the period studied, more than 20,000 received a prescription for an anti-GLP-1 drug, representing 0.6% of the cohort.

Prescriptions were more common among 11-year-olds than 8-year-olds, among girls rather than boys, and in areas with lower levels of social vulnerability. In France, some anti-obesity treatments can be prescribed to minors, but access remains very limited, notably because the drugs are not reimbursed.

“Despite this rapid increase, treatment remains largely reserved for children presenting metabolic complications of obesity,” Dr. Babak J. Orandi told Le Figaro.

Despite this rapid increase, treatment remains largely reserved for children presenting metabolic complications of obesity.

· Dr. Babak J. OrandiHe told Le Figaro that the growing use of anti-GLP-1 drugs remains concentrated among children with metabolic complications.
About this summary

Originally published by Le Figaro in French. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.

More Stories

From Our Blog